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Aging is a natural process that produces deleterious changes in all tissues of the 
organism. One leading theory about the cause of aging suggest that oxidative stress 
play a fundamental role in pathogenesis. Oxidative stress induces intracellular dam-
age that aff ects all biological components, including, DNA, lipids, sugars and pro-
teins. Therefore, the imbalance between intracellular reactive oxygen species (ROS) 
and antioxidant defence mechanisms results in harmful oxidative stress. One of the 
most widely considered strategies for preventing aging and for treating age-related 
disease is the use of natural anti-oxidant agents, such as melatonin and resveratrol.
Melatonin is a potent endogenous anti-oxidant neurohormone, which acts through 
various mechanisms to ameliorate the toxic eff ects of ROS. However, little is known 
about the mechanisms of signalling pathways through which melatonin acts to 
reverse the eff ects of ROS.
In the present study we treated ApoE-defi cient mice, a well-known senescence 
model, from 6th week to 15th week of life, with a specifi c melatonin formulation: 
Armonia Retard (kindly provided by Nathura s.r.l, Reggio Emilia, Italy), with an 
extended-release pharmacokinetic, at diff erent progressive doses 0.04, 0.1, 10 mg/
kg/day. We used the same treatment in C57BL6 mice, as control group. Vascular 
alterations were evaluated in aorta by morphology and immunoﬂ uorescence analy-
sis was focused on pleiotropic inﬂ ammatory markers, such as interleukins (IL) 6 and 
10, inducible nitric oxide synthase (iNOS), tumor necrosis factor-alpha (TNF-α). We 
observed in ApoE-defi cient mice endothelial cell detachment and  IL-6, IL-10, iNOS 
and TNF-α overexpression. Melatonin treatment improved not only the endothelial 
damage, but also the overall vascular cytoarchitecture and reduced inﬂ ammation and 
macrophages infi ltration. In particular, melatonin Retard at the highest dose, recov-
ered all the above markers to the levels of C57BL6 mice.
These results outline the anti-inﬂ ammatory and anti-oxidant properties of mel-
atonin and its benefi cial anti-aging and anti-atherosclerotic eff ects, especially in 
extended-release formulation.
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